Dr. Melhim Bou Alwan, MD

Dr. Bou Alwan practices at Wellstar West Georgia Medical Center in Lagrange, Georgia, part of Wellstar Health System.

Dr. Bou Alwan's NPI, 1164736542, was assigned on July 28, 2010. Dr. Bou Alwan holds Georgia license 68984.

Dr. Bou Alwan's primary practice is Wellstar West Georgia Medical Center, at 1514 Vernon Road, Lagrange, GA 30240 in Troup County. The practice phone is (706) 882-1411.

Dr. Bou Alwan's primary practice is Wellstar West Georgia Medical Center in Lagrange, Georgia, part of Wellstar Health System. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. Bou Alwan to 2 more skilled nursing facilities and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bou Alwan practices, 4 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Bou Alwan's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Bou Alwan is licensed in Georgia.

CMS data shows 1,859 Medicare services from Dr. Bou Alwan across 8 procedure codes in 2024, for 392 Medicare patients. Medicare paid $150,819 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 392 Medicare patients who saw Dr. Bou Alwan in 2024. The largest group is 85 and over, with 140 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bou Alwan's median patient age at 78, with 65% women.

In 2024, Dr. Bou Alwan wrote 31,392 Medicare Part D claims for 471 patients. 91% of them were for generic drugs. CMS names the drug for 30,893 of them, across 198 drugs with 11 or more claims each, at $633,873 in total drug cost. In 2023, CMS named 30,894 claims across 182 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Bou Alwan for performance year 2024, reported through an alternative payment model (APM). Dr. Bou Alwan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Bou Alwan in 2016. Dr. Bou Alwan's most frequent co-authors are Colleen Suzanne Kraft, MD and Nadine Georges Rouphael, MD.

CMS Open Payments shows 35 general payments to Dr. Bou Alwan from 13 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $129.